4.3 Article

Deeplasia: deep learning for bone age assessment validated on skeletal dysplasias

Journal

PEDIATRIC RADIOLOGY
Volume -, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1007/s00247-023-05789-1

Keywords

Artificial intelligence; Bone age measurement; Bone dysplasias; Children; Deep learning; Genetic diseases; Rare diseases

Ask authors/readers for more resources

This study presents Deeplasia, a deep-learning approach specifically validated for bone age assessment in patients with skeletal dysplasias. The results show that Deeplasia is competent in assessing bone age and monitoring development in both normal and dysplastic bones.
BackgroundSkeletal dysplasias collectively affect a large number of patients worldwide. Most of these disorders cause growth anomalies. Hence, evaluating skeletal maturity via the determination of bone age (BA) is a useful tool. Moreover, consecutive BA measurements are crucial for monitoring the growth of patients with such disorders, especially for timing hormonal treatment or orthopedic interventions. However, manual BA assessment is time-consuming and suffers from high intra- and inter-rater variability. This is further exacerbated by genetic disorders causing severe skeletal malformations. While numerous approaches to automate BA assessment have been proposed, few are validated for BA assessment on children with skeletal dysplasias.ObjectiveWe present Deeplasia, an open-source prior-free deep-learning approach designed for BA assessment specifically validated on patients with skeletal dysplasias.Materials and methodsWe trained multiple convolutional neural network models under various conditions and selected three to build a precise model ensemble. We utilized the public BA dataset from the Radiological Society of North America (RSNA) consisting of training, validation, and test subsets containing 12,611, 1,425, and 200 hand and wrist radiographs, respectively. For testing the performance of our model ensemble on dysplastic hands, we retrospectively collected 568 radiographs from 189 patients with molecularly confirmed diagnoses of seven different genetic bone disorders including achondroplasia and hypochondroplasia. A subset of the dysplastic cohort (149 images) was used to estimate the test-retest precision of our model ensemble on longitudinal data.ResultsThe mean absolute difference of Deeplasia for the RSNA test set (based on the average of six different reference ratings) and dysplastic set (based on the average of two different reference ratings) were 3.87 and 5.84 months, respectively. The test-retest precision of Deeplasia on longitudinal data (2.74 months) is estimated to be similar to a human expert.ConclusionWe demonstrated that Deeplasia is competent in assessing the age and monitoring the development of both normal and dysplastic bones.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available